These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9974379)

  • 1. Double fluorescent-amplification refractory mutation detection (dF-ARMS) of the factor V Leiden and prothrombin mutations.
    Maher C; Crowley D; Cullen C; Wall C; Royston D; Fanning S
    Thromb Haemost; 1999 Jan; 81(1):76-80. PubMed ID: 9974379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-color multiplex 5' nuclease assay for the simultaneous detection of the factor V Leiden and the prothrombin G20210A mutations.
    Ugozzoli LA; Hamby K
    Mol Cell Probes; 2004 Jun; 18(3):161-6. PubMed ID: 15135449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations.
    Koksal V; Baris I; Etlik O
    Exp Mol Pathol; 2007 Aug; 83(1):1-3. PubMed ID: 17275807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR.
    Mitterer M; Lanthaler AJ; Mair W; Giacomuzzi K; Coser P
    Haematologica; 1999 Mar; 84(3):204-7. PubMed ID: 10189382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
    Huber S; McMaster KJ; Voelkerding KV
    J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A whole-blood homogeneous assay for the multiplex detection of the factor V G1691A and the prothrombin G20210A mutations.
    Hobson-Peters J; Toye P
    Mol Cell Probes; 2005 Aug; 19(4):290-7. PubMed ID: 16006096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
    Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous genotyping for factor V Leiden and prothrombin G20210A variant by a multiplex PCR-SSCP assay on whole blood.
    Meyer M; Kutscher G; Vogel G
    Thromb Haemost; 1999 Jan; 81(1):162-3. PubMed ID: 10348711
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
    Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
    Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Roche LightCycler: a simple and rapid method for direct detection of factor V Leiden and prothrombin G20210A genotypes from blood samples without the need for DNA extraction.
    Cooper PC; Cooper SM; Smith JM; Kitchen S; Makris M
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):499-503. PubMed ID: 12851538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A very rapid multiplex polymerase chain reaction for simultaneous detection of factor V Leiden and G20210A prothrombin mutation.
    Corrêa MF; Rezende SM
    Clin Lab Haematol; 2004 Jun; 26(3):239-40. PubMed ID: 15163325
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of methods for detection of factor V Leiden and the prothrombin G20210A mutations.
    Cooper PC; Rezende SM
    Int J Lab Hematol; 2007 Jun; 29(3):153-62. PubMed ID: 17474891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex PCR-RFLP assay for detection of factor V Leiden and prothrombin G20210A.
    Baris I; Koksal V; Etlik O
    Genet Test; 2004; 8(4):381-3. PubMed ID: 15684866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercoagulability markers in young asymptomatic heterozygous carriers of factor V Leiden (G1691A) or prothrombin (G20210A) variant.
    Godoi LC; Fernandes AP; Vieira LM; Melgaço DA; de Bastos M; Ribeiro Mde F; Carvalho Md; Dusse LM
    Clin Chim Acta; 2006 Mar; 365(1-2):304-9. PubMed ID: 16256098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.